Resection: Clinical Trials

6 trials of Resection, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 terminated. 6 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 26Terminated 6
Phase 11Terminated 1

Follow Resection: new trials by email Literature Review of Resection trials Research Report on Resection

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Impact of Total Intravenous Anesthesia Following Cancer Surgery, TIVACS Study
Anesthesia Procedure, General Anesthesia Procedure, Resection - Pancreatic Adenocarcinoma
Phase 2TerminatedOhio State University Comprehensive Cancer Center82023-06-022025-07-10
Neoadjuvant Chemoradiotherapy With CRLX-101 and Capecitabine for Rectal Cancer
CRLX101, Capecitabine, Radiotherapy - Rectal Cancer
Phase 1 / Phase 2TerminatedUNC Lineberger Comprehensive Cancer Center322013-12-012020-11-03
CHFR Methylation Status Esophageal Cancer Study
Paclitaxel, Cisplatin, Oxaliplatin - Esophageal Cancer
Phase 2TerminatedSidney Kimmel Comprehensive Cancer Center at Johns Hopkins312011-06-012019-01-25
Preoperative Chemotherapy (Gemcitabine and Erlotinib) With or Without Radiation Therapy
Gemcitabine, Radiation Therapy, Erlotinib - Pancreatic Cancer
Phase 2TerminatedM.D. Anderson Cancer Center52008-09-012016-05-19
Docetaxel, Carboplatin, and Bevacizumab in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer That Can Be Removed By Surgery
bevacizumab, carboplatin, docetaxel - Lung Cancer
Phase 2TerminatedUniversity of California, San Francisco12005-12-012011-02-09
Carboplatin, Gemcitabine, and Thalidomide in Patients Undergoing Surgery for Stage II or III Non-Small Cell Lung Cancer
carboplatin, gemcitabine hydrochloride, thalidomide - Lung Cancer
Phase 2TerminatedMasonic Cancer Center, University of Minnesota222002-05-012017-12-28

Conditions studied

Carcinoma, Non-Small-Cell Lung (2)  ·  Lung Neoplasms (2)  ·  Adenocarcinoma of Lung (1)  ·  Colorectal Neoplasms (1)  ·  Esophageal Neoplasms (1)  ·  Pancreatic Neoplasms (1)  ·  Rectal Neoplasms (1)

Sponsors

M.D. Anderson Cancer Center (1)  ·  Masonic Cancer Center, University of Minnesota (1)  ·  Ohio State University Comprehensive Cancer Center (1)  ·  Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (1)  ·  UNC Lineberger Comprehensive Cancer Center (1)  ·  University of California, San Francisco (1)

Countries

United States (6)

Top investigators

Andrew Wang, MD (1)  ·  Arkadiusz Dudek, MD (1)  ·  Aslam Ejaz, MD (1)  ·  Jason B. Fleming, MD (1)  ·  Ronan Kelly, M.D. (1)  ·  Sarita Dubey, MD (1)

Results publications

PMID 27784746, PMID 30858085

NIH funding

R33CA127055 (1)